Ustekinumab injection is used to treat moderate to severe plaque psoriasis (a skin disease in which red, scaly patches form on some areas of the body) in people whose psoriasis is too severe to be treated by topical medications alone. Ustekinumab injection is in a class of medications called monoclonal antibodies. It works by stopping the action of certain cells in the body that cause the symptoms of psoriasis.
STELARA Available Drugs :
STELARA ndc# 57894-060by Janssen Biotech, Inc.
SUBCUTANEOUS INJECTION, SOLUTION with active strength of 45 mg/.5mLstarted marketing at 25/09/2009 .
STELARA ndc# 57894-061by Janssen Biotech, Inc.
SUBCUTANEOUS INJECTION, SOLUTION with active strength of 90 mg/mLstarted marketing at 25/09/2009 .
STELARA Search Trends: